Dr. K.P. Aravindan

Bio Miracle Life Sciences Pvt. Ltd, based in Pune, India, is aggressively marketing a blood test that they claim can detect “persons at risk of cancers, one year before the currently used diagnostic imaging methods can barely detect the presence of cancer cells in the body.” The discoverer is said to be Dr. MB Sahasrabudhe, a former dean of the TATA Cancer Research Institute in Mumbai. The test is claimed to detect, by immunoassay, lymphocytes sensitized against a common cancer antigen‚ or “tumor mimetic antigen,” which the promoters claim is shared by all cancers. They claim that the test has a sensitivity of 83.33% and specificity of 96.87%. My colleagues and I believe that this test has no scientific merit whatsoever and is deceptively marketed. …